

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 7.66353052 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 7.19327823 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 7.19327823 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 7.03477852 |
| 5 | respiratory electron transport chain (GO:0022904) | 6.05314365 |
| 6 | electron transport chain (GO:0022900) | 5.91845482 |
| 7 | chaperone-mediated protein transport (GO:0072321) | 5.66649733 |
| 8 | protein neddylation (GO:0045116) | 5.62796135 |
| 9 | protein complex biogenesis (GO:0070271) | 4.35678096 |
| 10 | sequestering of actin monomers (GO:0042989) | 4.22856092 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 4.09826013 |
| 12 | hydrogen ion transmembrane transport (GO:1902600) | 4.05740026 |
| 13 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.03170329 |
| 14 | NADH dehydrogenase complex assembly (GO:0010257) | 4.03170329 |
| 15 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.03170329 |
| 16 | protein maturation by protein folding (GO:0022417) | 3.92795920 |
| 17 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.88654365 |
| 18 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.86388219 |
| 19 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.83850737 |
| 20 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.83850737 |
| 21 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.79735228 |
| 22 | fatty acid elongation (GO:0030497) | 3.67055734 |
| 23 | synaptic vesicle exocytosis (GO:0016079) | 3.65025044 |
| 24 | proton transport (GO:0015992) | 3.64638816 |
| 25 | presynaptic membrane assembly (GO:0097105) | 3.62172174 |
| 26 | ATP biosynthetic process (GO:0006754) | 3.60328511 |
| 27 | glutamate secretion (GO:0014047) | 3.57821854 |
| 28 | hydrogen transport (GO:0006818) | 3.56024107 |
| 29 | synaptic vesicle maturation (GO:0016188) | 3.52124307 |
| 30 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.43777135 |
| 31 | transferrin transport (GO:0033572) | 3.42154155 |
| 32 | cullin deneddylation (GO:0010388) | 3.38750484 |
| 33 | proteasome assembly (GO:0043248) | 3.37223765 |
| 34 | presynaptic membrane organization (GO:0097090) | 3.36641403 |
| 35 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.35631399 |
| 36 | substantia nigra development (GO:0021762) | 3.27700553 |
| 37 | dopamine transport (GO:0015872) | 3.23006305 |
| 38 | central nervous system myelination (GO:0022010) | 3.22586239 |
| 39 | axon ensheathment in central nervous system (GO:0032291) | 3.22586239 |
| 40 | ferric iron transport (GO:0015682) | 3.15238151 |
| 41 | trivalent inorganic cation transport (GO:0072512) | 3.15238151 |
| 42 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.14464530 |
| 43 | inner mitochondrial membrane organization (GO:0007007) | 3.13093402 |
| 44 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.12551119 |
| 45 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.12551119 |
| 46 | protein deneddylation (GO:0000338) | 3.11921515 |
| 47 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.11103288 |
| 48 | negative regulation of response to food (GO:0032096) | 3.10389049 |
| 49 | negative regulation of appetite (GO:0032099) | 3.10389049 |
| 50 | respiratory chain complex IV assembly (GO:0008535) | 3.10175876 |
| 51 | regulation of catecholamine metabolic process (GO:0042069) | 3.08658387 |
| 52 | regulation of dopamine metabolic process (GO:0042053) | 3.08658387 |
| 53 | positive regulation of neurotransmitter transport (GO:0051590) | 3.01419348 |
| 54 | regulation of synapse structural plasticity (GO:0051823) | 3.00185282 |
| 55 | regulation of autophagic vacuole assembly (GO:2000785) | 2.99669346 |
| 56 | cytochrome complex assembly (GO:0017004) | 2.96316730 |
| 57 | phagosome maturation (GO:0090382) | 2.91803238 |
| 58 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.90631157 |
| 59 | neuronal action potential propagation (GO:0019227) | 2.89891295 |
| 60 | dopamine biosynthetic process (GO:0042416) | 2.86887010 |
| 61 | GTP biosynthetic process (GO:0006183) | 2.85847316 |
| 62 | regulation of protein kinase A signaling (GO:0010738) | 2.85829786 |
| 63 | regulation of glutamate secretion (GO:0014048) | 2.84560215 |
| 64 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.83613035 |
| 65 | regulation of cilium movement (GO:0003352) | 2.82099572 |
| 66 | protein targeting to mitochondrion (GO:0006626) | 2.81902283 |
| 67 | positive regulation of synapse assembly (GO:0051965) | 2.79269020 |
| 68 | establishment of protein localization to mitochondrion (GO:0072655) | 2.78859454 |
| 69 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.77822222 |
| 70 | protein localization to synapse (GO:0035418) | 2.77687955 |
| 71 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.76386388 |
| 72 | L-phenylalanine metabolic process (GO:0006558) | 2.76386388 |
| 73 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.74065080 |
| 74 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.72864522 |
| 75 | L-phenylalanine catabolic process (GO:0006559) | 2.72864522 |
| 76 | vocalization behavior (GO:0071625) | 2.71831189 |
| 77 | protein insertion into membrane (GO:0051205) | 2.71793283 |
| 78 | negative regulation of microtubule polymerization (GO:0031115) | 2.71330197 |
| 79 | platelet dense granule organization (GO:0060155) | 2.70726664 |
| 80 | regulation of vacuole organization (GO:0044088) | 2.70408560 |
| 81 | response to misfolded protein (GO:0051788) | 2.70018061 |
| 82 | dendritic spine morphogenesis (GO:0060997) | 2.69902906 |
| 83 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.69523137 |
| 84 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.68776717 |
| 85 | positive regulation of TOR signaling (GO:0032008) | 2.67845894 |
| 86 | viral protein processing (GO:0019082) | 2.66289746 |
| 87 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.66190367 |
| 88 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.66190367 |
| 89 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.65235833 |
| 90 | cerebellar Purkinje cell layer development (GO:0021680) | 2.64603506 |
| 91 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.63670070 |
| 92 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.63283523 |
| 93 | negative regulation of neurotransmitter transport (GO:0051589) | 2.62807421 |
| 94 | protein localization to cilium (GO:0061512) | 2.62648713 |
| 95 | regulation of microtubule-based movement (GO:0060632) | 2.61914532 |
| 96 | protein localization to mitochondrion (GO:0070585) | 2.61610994 |
| 97 | neurotransmitter secretion (GO:0007269) | 2.61338567 |
| 98 | regulation of vesicle fusion (GO:0031338) | 2.61140562 |
| 99 | postsynaptic membrane organization (GO:0001941) | 2.60857839 |
| 100 | positive regulation of action potential (GO:0045760) | 2.60678163 |
| 101 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.59025830 |
| 102 | neurotransmitter uptake (GO:0001504) | 2.58509213 |
| 103 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.58279976 |
| 104 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.57660891 |
| 105 | oxidative phosphorylation (GO:0006119) | 2.57323180 |
| 106 | response to redox state (GO:0051775) | 2.57085789 |
| 107 | neuron recognition (GO:0008038) | 2.56788395 |
| 108 | viral transcription (GO:0019083) | 2.56381145 |
| 109 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.55991534 |
| 110 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.55713363 |
| 111 | transmission of nerve impulse (GO:0019226) | 2.55321049 |
| 112 | neurofilament cytoskeleton organization (GO:0060052) | 2.52516516 |
| 113 | positive regulation of mitochondrial fission (GO:0090141) | 2.52022020 |
| 114 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.51841581 |
| 115 | response to gravity (GO:0009629) | 2.51241365 |
| 116 | synaptic transmission, glutamatergic (GO:0035249) | 2.50717825 |
| 117 | synaptic transmission, dopaminergic (GO:0001963) | 2.49119375 |
| 118 | regulation of oxidative phosphorylation (GO:0002082) | 2.48952075 |
| 119 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.48898929 |
| 120 | protein localization to endoplasmic reticulum (GO:0070972) | 2.48767092 |
| 121 | negative regulation of heart rate (GO:0010459) | 2.48755451 |
| 122 | virion assembly (GO:0019068) | 2.48043823 |
| 123 | protein targeting to ER (GO:0045047) | 2.47677725 |
| 124 | membrane assembly (GO:0071709) | 2.47106416 |
| 125 | cotranslational protein targeting to membrane (GO:0006613) | 2.46796977 |
| 126 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.45979786 |
| 127 | cellular potassium ion homeostasis (GO:0030007) | 2.43299838 |
| 128 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.43058029 |
| 129 | positive regulation of actin filament depolymerization (GO:0030836) | 2.43042512 |
| 130 | mitochondrial transport (GO:0006839) | 2.39991554 |
| 131 | catecholamine transport (GO:0051937) | 2.39462132 |
| 132 | behavioral response to cocaine (GO:0048148) | 2.38433145 |
| 133 | neural nucleus development (GO:0048857) | 2.38387250 |
| 134 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.37354103 |
| 135 | translational termination (GO:0006415) | 2.37177906 |
| 136 | mannosylation (GO:0097502) | 2.35208851 |
| 137 | regulation of mitochondrial translation (GO:0070129) | 2.34923684 |
| 138 | response to cocaine (GO:0042220) | 2.34868163 |
| 139 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.34062985 |
| 140 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.31728953 |
| 141 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.31728953 |
| 142 | synaptic vesicle transport (GO:0048489) | 2.31333381 |
| 143 | establishment of synaptic vesicle localization (GO:0097480) | 2.31333381 |
| 144 | regulation of cellular amine metabolic process (GO:0033238) | 2.31247457 |
| 145 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.30569467 |
| 146 | neuron-neuron synaptic transmission (GO:0007270) | 2.27729817 |
| 147 | regulation of cellular respiration (GO:0043457) | 2.27174804 |
| 148 | anterograde synaptic vesicle transport (GO:0048490) | 2.22528736 |
| 149 | negative regulation of cation channel activity (GO:2001258) | 2.21855731 |
| 150 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.21071560 |
| 151 | regulation of synaptic vesicle transport (GO:1902803) | 2.20440076 |
| 152 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.20383412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.37045573 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.39109016 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.44084746 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.12428081 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.88120465 |
| 6 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.83879736 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.78769018 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.64401195 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.53769584 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.47781579 |
| 11 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.44851612 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.36840936 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36104953 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.30336183 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24492740 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.22245101 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.21296376 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.20594672 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.18959492 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.16144261 |
| 21 | VDR_22108803_ChIP-Seq_LS180_Human | 2.14998835 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.11082694 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.08954160 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.02907689 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.02907689 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.99466462 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.97022199 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.92834926 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.91102820 |
| 30 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.86349403 |
| 31 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.85216329 |
| 32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.83956425 |
| 33 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.82393774 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.81144537 |
| 35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.80569517 |
| 36 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.77365306 |
| 37 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.75911683 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.75340076 |
| 39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.72788773 |
| 40 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.71564972 |
| 41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71559381 |
| 42 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.71480964 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.70583816 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.68291821 |
| 45 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.66037057 |
| 46 | FUS_26573619_Chip-Seq_HEK293_Human | 1.62648839 |
| 47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59789598 |
| 48 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.57940924 |
| 49 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.53520674 |
| 50 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.53134692 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.52683105 |
| 52 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.51949847 |
| 53 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49422841 |
| 54 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.49144751 |
| 55 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.48479542 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.45337094 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.44913219 |
| 58 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.42946134 |
| 59 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.42282189 |
| 60 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.42062726 |
| 61 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.42055670 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41705993 |
| 63 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.40518261 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.39173148 |
| 65 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39166407 |
| 66 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38363692 |
| 67 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.38265042 |
| 68 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.37612533 |
| 69 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.36745115 |
| 70 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.35010717 |
| 71 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.32528393 |
| 72 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.29630911 |
| 73 | JUN_21703547_ChIP-Seq_K562_Human | 1.29005203 |
| 74 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.28589863 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.27936877 |
| 76 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25834331 |
| 77 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.25815765 |
| 78 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.24569005 |
| 79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23845016 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22710574 |
| 81 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22369635 |
| 82 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.20716889 |
| 83 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.20199179 |
| 84 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20127875 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19500281 |
| 86 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.17878625 |
| 87 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.16984653 |
| 88 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.16033612 |
| 89 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16018140 |
| 90 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15590381 |
| 91 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15276809 |
| 92 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13005506 |
| 93 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12052921 |
| 94 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11405774 |
| 95 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.10883155 |
| 96 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.10782537 |
| 97 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.10318395 |
| 98 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10142463 |
| 99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09582692 |
| 100 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.09538129 |
| 101 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.09398051 |
| 102 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08699213 |
| 103 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.08557846 |
| 104 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.08046876 |
| 105 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.07694184 |
| 106 | EWS_26573619_Chip-Seq_HEK293_Human | 1.07597410 |
| 107 | P68_20966046_ChIP-Seq_HELA_Human | 1.06980411 |
| 108 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.06224963 |
| 109 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.05486269 |
| 110 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04974194 |
| 111 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03929871 |
| 112 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03452732 |
| 113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03138730 |
| 114 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02178499 |
| 115 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.01345554 |
| 116 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.00871291 |
| 117 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.00131418 |
| 118 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.99972862 |
| 119 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99625642 |
| 120 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99139598 |
| 121 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.97180553 |
| 122 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.96482209 |
| 123 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96078532 |
| 124 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95702205 |
| 125 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94903775 |
| 126 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.94860805 |
| 127 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.94363110 |
| 128 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94159528 |
| 129 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.93289898 |
| 130 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.92693225 |
| 131 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92037764 |
| 132 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91583669 |
| 133 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.90897149 |
| 134 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90484630 |
| 135 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90430001 |
| 136 | SA1_27219007_Chip-Seq_Bcells_Human | 0.90232388 |
| 137 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90102569 |
| 138 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89184092 |
| 139 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.88362515 |
| 140 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.87904954 |
| 141 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87877993 |
| 142 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.87797563 |
| 143 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87729910 |
| 144 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87729910 |
| 145 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87600022 |
| 146 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86749118 |
| 147 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86411284 |
| 148 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.86391201 |
| 149 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.86239464 |
| 150 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.86201688 |
| 151 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.85660556 |
| 152 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85249041 |
| 153 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85157871 |
| 154 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.82546876 |
| 155 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.82500481 |
| 156 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82209540 |
| 157 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81732472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.87108337 |
| 2 | MP0001529_abnormal_vocalization | 3.85548448 |
| 3 | MP0006276_abnormal_autonomic_nervous | 3.43152127 |
| 4 | MP0001905_abnormal_dopamine_level | 3.12385656 |
| 5 | MP0003123_paternal_imprinting | 2.83617850 |
| 6 | MP0001968_abnormal_touch/_nociception | 2.74566099 |
| 7 | MP0004270_analgesia | 2.61682971 |
| 8 | MP0002736_abnormal_nociception_after | 2.57706889 |
| 9 | MP0002734_abnormal_mechanical_nocicepti | 2.54864198 |
| 10 | MP0009046_muscle_twitch | 2.54564116 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.54382542 |
| 12 | MP0002064_seizures | 2.53444566 |
| 13 | MP0009745_abnormal_behavioral_response | 2.49222950 |
| 14 | MP0001984_abnormal_olfaction | 2.46451361 |
| 15 | MP0002272_abnormal_nervous_system | 2.45104509 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.38013628 |
| 17 | MP0004859_abnormal_synaptic_plasticity | 2.37963464 |
| 18 | MP0002653_abnormal_ependyma_morphology | 2.31104653 |
| 19 | MP0004142_abnormal_muscle_tone | 2.30473561 |
| 20 | MP0002572_abnormal_emotion/affect_behav | 2.20005335 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 2.19924583 |
| 22 | MP0010386_abnormal_urinary_bladder | 2.13360663 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.11893637 |
| 24 | MP0002063_abnormal_learning/memory/cond | 2.07881219 |
| 25 | MP0001970_abnormal_pain_threshold | 2.05007291 |
| 26 | MP0001440_abnormal_grooming_behavior | 1.99465289 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.97416008 |
| 28 | MP0001501_abnormal_sleep_pattern | 1.96823856 |
| 29 | MP0009379_abnormal_foot_pigmentation | 1.96185083 |
| 30 | MP0001188_hyperpigmentation | 1.91973120 |
| 31 | MP0003122_maternal_imprinting | 1.87531006 |
| 32 | MP0001486_abnormal_startle_reflex | 1.84765250 |
| 33 | MP0002837_dystrophic_cardiac_calcinosis | 1.81906334 |
| 34 | MP0002822_catalepsy | 1.77581951 |
| 35 | MP0002184_abnormal_innervation | 1.77499267 |
| 36 | MP0000778_abnormal_nervous_system | 1.76280727 |
| 37 | MP0003186_abnormal_redox_activity | 1.75061273 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.74777207 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.74192948 |
| 40 | MP0004924_abnormal_behavior | 1.65900005 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.65900005 |
| 42 | MP0005171_absent_coat_pigmentation | 1.63817724 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.62463508 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.48989858 |
| 45 | MP0001986_abnormal_taste_sensitivity | 1.47872564 |
| 46 | MP0000920_abnormal_myelination | 1.47557474 |
| 47 | MP0002638_abnormal_pupillary_reflex | 1.45393959 |
| 48 | MP0004742_abnormal_vestibular_system | 1.42908228 |
| 49 | MP0003011_delayed_dark_adaptation | 1.42779762 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.42487169 |
| 51 | MP0000372_irregular_coat_pigmentation | 1.35437708 |
| 52 | MP0005409_darkened_coat_color | 1.35029264 |
| 53 | MP0002557_abnormal_social/conspecific_i | 1.34405960 |
| 54 | MP0004510_myositis | 1.30030611 |
| 55 | MP0005646_abnormal_pituitary_gland | 1.29400338 |
| 56 | MP0005551_abnormal_eye_electrophysiolog | 1.24959310 |
| 57 | MP0002882_abnormal_neuron_morphology | 1.22974445 |
| 58 | MP0002876_abnormal_thyroid_physiology | 1.19783677 |
| 59 | MP0003121_genomic_imprinting | 1.19278023 |
| 60 | MP0002751_abnormal_autonomic_nervous | 1.18853056 |
| 61 | MP0002163_abnormal_gland_morphology | 1.17391977 |
| 62 | MP0003638_abnormal_response/metabolism_ | 1.16942717 |
| 63 | MP0002066_abnormal_motor_capabilities/c | 1.15385017 |
| 64 | MP0004885_abnormal_endolymph | 1.14846196 |
| 65 | MP0008789_abnormal_olfactory_epithelium | 1.14614265 |
| 66 | MP0003633_abnormal_nervous_system | 1.13339633 |
| 67 | MP0000751_myopathy | 1.11599713 |
| 68 | MP0003329_amyloid_beta_deposits | 1.11208602 |
| 69 | MP0005394_taste/olfaction_phenotype | 1.07409947 |
| 70 | MP0005499_abnormal_olfactory_system | 1.07409947 |
| 71 | MP0000343_altered_response_to | 1.07395166 |
| 72 | MP0004133_heterotaxia | 1.06323093 |
| 73 | MP0001756_abnormal_urination | 1.05084503 |
| 74 | MP0008569_lethality_at_weaning | 1.04698920 |
| 75 | MP0000955_abnormal_spinal_cord | 1.04685216 |
| 76 | MP0002752_abnormal_somatic_nervous | 1.03303351 |
| 77 | MP0002229_neurodegeneration | 1.00882817 |
| 78 | MP0003075_altered_response_to | 1.00181052 |
| 79 | MP0001485_abnormal_pinna_reflex | 0.99227225 |
| 80 | MP0006035_abnormal_mitochondrial_morpho | 0.99176921 |
| 81 | MP0003136_yellow_coat_color | 0.98011372 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.96409535 |
| 83 | MP0003634_abnormal_glial_cell | 0.96374469 |
| 84 | MP0004811_abnormal_neuron_physiology | 0.95495780 |
| 85 | MP0006072_abnormal_retinal_apoptosis | 0.95226679 |
| 86 | MP0001502_abnormal_circadian_rhythm | 0.94741662 |
| 87 | MP0005379_endocrine/exocrine_gland_phen | 0.94260836 |
| 88 | MP0000013_abnormal_adipose_tissue | 0.91732387 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 0.91566597 |
| 90 | MP0006292_abnormal_olfactory_placode | 0.90765762 |
| 91 | MP0000538_abnormal_urinary_bladder | 0.90638249 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.88421082 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.87291027 |
| 94 | MP0003879_abnormal_hair_cell | 0.86284013 |
| 95 | MP0000026_abnormal_inner_ear | 0.84965577 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.84781885 |
| 97 | MP0005410_abnormal_fertilization | 0.84466254 |
| 98 | MP0002090_abnormal_vision | 0.82688051 |
| 99 | MP0005503_abnormal_tendon_morphology | 0.82515843 |
| 100 | MP0005083_abnormal_biliary_tract | 0.82430851 |
| 101 | MP0002295_abnormal_pulmonary_circulatio | 0.82180213 |
| 102 | MP0003787_abnormal_imprinting | 0.81907432 |
| 103 | MP0008872_abnormal_physiological_respon | 0.80654214 |
| 104 | MP0003938_abnormal_ear_development | 0.79182876 |
| 105 | MP0008875_abnormal_xenobiotic_pharmacok | 0.77501536 |
| 106 | MP0000639_abnormal_adrenal_gland | 0.75225196 |
| 107 | MP0002938_white_spotting | 0.75181884 |
| 108 | MP0001727_abnormal_embryo_implantation | 0.74791103 |
| 109 | MP0001542_abnormal_bone_strength | 0.74063812 |
| 110 | MP0004019_abnormal_vitamin_homeostasis | 0.73420528 |
| 111 | MP0004134_abnormal_chest_morphology | 0.73187479 |
| 112 | MP0005636_abnormal_mineral_homeostasis | 0.73074997 |
| 113 | MP0002102_abnormal_ear_morphology | 0.72452535 |
| 114 | MP0008004_abnormal_stomach_pH | 0.71725138 |
| 115 | MP0004085_abnormal_heartbeat | 0.68630243 |
| 116 | MP0001664_abnormal_digestion | 0.68626254 |
| 117 | MP0005535_abnormal_body_temperature | 0.67897132 |
| 118 | MP0004036_abnormal_muscle_relaxation | 0.66429167 |
| 119 | MP0002152_abnormal_brain_morphology | 0.66239804 |
| 120 | MP0004145_abnormal_muscle_electrophysio | 0.65581743 |
| 121 | MP0009250_abnormal_appendicular_skeleto | 0.65135845 |
| 122 | MP0004381_abnormal_hair_follicle | 0.63642951 |
| 123 | MP0005253_abnormal_eye_physiology | 0.63355702 |
| 124 | MP0005084_abnormal_gallbladder_morpholo | 0.60747072 |
| 125 | MP0002069_abnormal_eating/drinking_beha | 0.60041564 |
| 126 | MP0002332_abnormal_exercise_endurance | 0.57987679 |
| 127 | MP0003631_nervous_system_phenotype | 0.57825136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 6.71752571 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 6.00884819 |
| 3 | Mitochondrial inheritance (HP:0001427) | 5.78033932 |
| 4 | Progressive macrocephaly (HP:0004481) | 5.75133307 |
| 5 | Acute encephalopathy (HP:0006846) | 5.23891570 |
| 6 | Hepatocellular necrosis (HP:0001404) | 4.79350331 |
| 7 | Increased CSF lactate (HP:0002490) | 4.77915528 |
| 8 | Increased hepatocellular lipid droplets (HP:0006565) | 4.32459448 |
| 9 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.14027388 |
| 10 | Renal Fanconi syndrome (HP:0001994) | 4.13612755 |
| 11 | Myokymia (HP:0002411) | 4.04597812 |
| 12 | Focal motor seizures (HP:0011153) | 3.85096152 |
| 13 | Hepatic necrosis (HP:0002605) | 3.78410963 |
| 14 | Abnormality of glycolysis (HP:0004366) | 3.74263358 |
| 15 | Increased serum pyruvate (HP:0003542) | 3.74263358 |
| 16 | Lipid accumulation in hepatocytes (HP:0006561) | 3.65466168 |
| 17 | Optic disc pallor (HP:0000543) | 3.59442391 |
| 18 | Leukodystrophy (HP:0002415) | 3.54350260 |
| 19 | Parakeratosis (HP:0001036) | 3.53766857 |
| 20 | Neuroendocrine neoplasm (HP:0100634) | 3.48085662 |
| 21 | 3-Methylglutaconic aciduria (HP:0003535) | 3.44571796 |
| 22 | Hypothermia (HP:0002045) | 3.43611719 |
| 23 | Pheochromocytoma (HP:0002666) | 3.43481154 |
| 24 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.40182548 |
| 25 | Respiratory failure (HP:0002878) | 3.29810007 |
| 26 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.26059249 |
| 27 | Increased intramyocellular lipid droplets (HP:0012240) | 3.18375770 |
| 28 | Atonic seizures (HP:0010819) | 3.16797223 |
| 29 | Exercise intolerance (HP:0003546) | 3.16697966 |
| 30 | Cerebral edema (HP:0002181) | 3.16190034 |
| 31 | Focal dystonia (HP:0004373) | 3.11399685 |
| 32 | Limb dystonia (HP:0002451) | 3.09160588 |
| 33 | Abnormal hair whorl (HP:0010721) | 2.98752374 |
| 34 | Craniofacial dystonia (HP:0012179) | 2.95672319 |
| 35 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.90982251 |
| 36 | Lactic acidosis (HP:0003128) | 2.88977858 |
| 37 | Purpura (HP:0000979) | 2.88118935 |
| 38 | Medial flaring of the eyebrow (HP:0010747) | 2.79130403 |
| 39 | Exertional dyspnea (HP:0002875) | 2.77694160 |
| 40 | Gait imbalance (HP:0002141) | 2.70561691 |
| 41 | Abnormality of renal resorption (HP:0011038) | 2.70460604 |
| 42 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.70170975 |
| 43 | Retinal dysplasia (HP:0007973) | 2.68751813 |
| 44 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.65934310 |
| 45 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.65934310 |
| 46 | Torticollis (HP:0000473) | 2.65485944 |
| 47 | Generalized aminoaciduria (HP:0002909) | 2.64459122 |
| 48 | Increased serum lactate (HP:0002151) | 2.63602604 |
| 49 | Epileptic encephalopathy (HP:0200134) | 2.61108051 |
| 50 | Absence seizures (HP:0002121) | 2.58438488 |
| 51 | Sensory axonal neuropathy (HP:0003390) | 2.57992221 |
| 52 | Congenital primary aphakia (HP:0007707) | 2.51742314 |
| 53 | X-linked dominant inheritance (HP:0001423) | 2.51199668 |
| 54 | Increased muscle lipid content (HP:0009058) | 2.48872366 |
| 55 | Poor suck (HP:0002033) | 2.44936331 |
| 56 | Hyperthyroidism (HP:0000836) | 2.41771169 |
| 57 | Petechiae (HP:0000967) | 2.39006794 |
| 58 | Nephrogenic diabetes insipidus (HP:0009806) | 2.38091021 |
| 59 | Vaginal atresia (HP:0000148) | 2.36339198 |
| 60 | Dialeptic seizures (HP:0011146) | 2.36314130 |
| 61 | Respiratory difficulties (HP:0002880) | 2.36259247 |
| 62 | Genital tract atresia (HP:0001827) | 2.34461209 |
| 63 | Agitation (HP:0000713) | 2.33650224 |
| 64 | Menorrhagia (HP:0000132) | 2.32760321 |
| 65 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.26552012 |
| 66 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.26552012 |
| 67 | Focal seizures (HP:0007359) | 2.25288208 |
| 68 | Abnormal pupillary function (HP:0007686) | 2.24262237 |
| 69 | Polyphagia (HP:0002591) | 2.19924745 |
| 70 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.18821275 |
| 71 | Glycosuria (HP:0003076) | 2.18111922 |
| 72 | Abnormality of urine glucose concentration (HP:0011016) | 2.18111922 |
| 73 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.11999816 |
| 74 | Mutism (HP:0002300) | 2.10671330 |
| 75 | Progressive cerebellar ataxia (HP:0002073) | 2.08166549 |
| 76 | Emotional lability (HP:0000712) | 2.06410600 |
| 77 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.05971487 |
| 78 | Febrile seizures (HP:0002373) | 2.05433274 |
| 79 | Visual hallucinations (HP:0002367) | 2.04772891 |
| 80 | Hyperventilation (HP:0002883) | 2.03691481 |
| 81 | Anxiety (HP:0000739) | 2.03089862 |
| 82 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.98100147 |
| 83 | Action tremor (HP:0002345) | 1.96694897 |
| 84 | Abnormal number of erythroid precursors (HP:0012131) | 1.93376324 |
| 85 | Cerebral hemorrhage (HP:0001342) | 1.90717206 |
| 86 | Epileptiform EEG discharges (HP:0011182) | 1.89842511 |
| 87 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.89771015 |
| 88 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.89771015 |
| 89 | Abnormality of magnesium homeostasis (HP:0004921) | 1.89591695 |
| 90 | Esotropia (HP:0000565) | 1.89179422 |
| 91 | Neurofibrillary tangles (HP:0002185) | 1.87969440 |
| 92 | Cerebral hypomyelination (HP:0006808) | 1.87199977 |
| 93 | Delusions (HP:0000746) | 1.86662725 |
| 94 | Upper limb muscle weakness (HP:0003484) | 1.86317526 |
| 95 | Prolonged neonatal jaundice (HP:0006579) | 1.85281745 |
| 96 | Amblyopia (HP:0000646) | 1.82840615 |
| 97 | EEG with generalized epileptiform discharges (HP:0011198) | 1.80256015 |
| 98 | Lethargy (HP:0001254) | 1.79727537 |
| 99 | CNS demyelination (HP:0007305) | 1.79370122 |
| 100 | Macrocytic anemia (HP:0001972) | 1.78592463 |
| 101 | Amniotic constriction ring (HP:0009775) | 1.78174034 |
| 102 | Abnormality of placental membranes (HP:0011409) | 1.78174034 |
| 103 | Generalized tonic-clonic seizures (HP:0002069) | 1.77909984 |
| 104 | Abnormal gallbladder physiology (HP:0012438) | 1.76018923 |
| 105 | Cholecystitis (HP:0001082) | 1.76018923 |
| 106 | Abnormality of binocular vision (HP:0011514) | 1.74230818 |
| 107 | Diplopia (HP:0000651) | 1.74230818 |
| 108 | Hyperphosphaturia (HP:0003109) | 1.73299813 |
| 109 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.72961012 |
| 110 | Hypsarrhythmia (HP:0002521) | 1.72438968 |
| 111 | Cerebral inclusion bodies (HP:0100314) | 1.69914166 |
| 112 | Growth hormone excess (HP:0000845) | 1.67945641 |
| 113 | Methylmalonic acidemia (HP:0002912) | 1.66892376 |
| 114 | Abnormal urine phosphate concentration (HP:0012599) | 1.66608195 |
| 115 | Autoamputation (HP:0001218) | 1.66268587 |
| 116 | Broad-based gait (HP:0002136) | 1.65679249 |
| 117 | Failure to thrive in infancy (HP:0001531) | 1.65648012 |
| 118 | Akinesia (HP:0002304) | 1.65207187 |
| 119 | Progressive inability to walk (HP:0002505) | 1.64973045 |
| 120 | Axonal loss (HP:0003447) | 1.64527115 |
| 121 | Spastic tetraplegia (HP:0002510) | 1.64313976 |
| 122 | Rhinitis (HP:0012384) | 1.63943640 |
| 123 | Specific learning disability (HP:0001328) | 1.59490558 |
| 124 | Abnormality of the corticospinal tract (HP:0002492) | 1.58531823 |
| 125 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.58356150 |
| 126 | Supranuclear gaze palsy (HP:0000605) | 1.58191808 |
| 127 | Diminished movement (HP:0002374) | 1.57124009 |
| 128 | Septate vagina (HP:0001153) | 1.56883373 |
| 129 | Poor coordination (HP:0002370) | 1.55378178 |
| 130 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.52671577 |
| 131 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.52605511 |
| 132 | Abnormal ciliary motility (HP:0012262) | 1.52413283 |
| 133 | Renal tubular dysfunction (HP:0000124) | 1.50322576 |
| 134 | Abnormal eating behavior (HP:0100738) | 1.48501294 |
| 135 | Psychosis (HP:0000709) | 1.47822008 |
| 136 | Delayed gross motor development (HP:0002194) | 1.47746657 |
| 137 | Short tibia (HP:0005736) | 1.47020985 |
| 138 | Myotonia (HP:0002486) | 1.46293327 |
| 139 | Blindness (HP:0000618) | 1.46151124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 3.91159879 |
| 2 | CASK | 3.56192220 |
| 3 | NME1 | 2.96139225 |
| 4 | ARAF | 2.90860155 |
| 5 | VRK2 | 2.82248636 |
| 6 | STK16 | 2.53419332 |
| 7 | STK39 | 2.42941615 |
| 8 | LIMK1 | 2.36794208 |
| 9 | MAP2K7 | 2.30928995 |
| 10 | CDK19 | 2.25470635 |
| 11 | OXSR1 | 2.17688504 |
| 12 | MST4 | 2.11313719 |
| 13 | MARK1 | 2.05690967 |
| 14 | TNIK | 2.00330324 |
| 15 | GRK7 | 1.90917824 |
| 16 | BCR | 1.89575814 |
| 17 | MYLK | 1.86784805 |
| 18 | GRK5 | 1.81502998 |
| 19 | MAP3K11 | 1.79075101 |
| 20 | BMPR1B | 1.68329981 |
| 21 | NTRK3 | 1.68220368 |
| 22 | MAP3K4 | 1.63338868 |
| 23 | PLK2 | 1.62916861 |
| 24 | PBK | 1.59092048 |
| 25 | MINK1 | 1.55913641 |
| 26 | MAPKAPK5 | 1.54411333 |
| 27 | BCKDK | 1.54082345 |
| 28 | PIM2 | 1.49881098 |
| 29 | MAPK13 | 1.47737583 |
| 30 | BMPR2 | 1.42934700 |
| 31 | ADRBK2 | 1.39957664 |
| 32 | UHMK1 | 1.35697672 |
| 33 | PNCK | 1.34417915 |
| 34 | PINK1 | 1.34304923 |
| 35 | BRAF | 1.32779554 |
| 36 | WNK4 | 1.30334577 |
| 37 | DYRK2 | 1.24890431 |
| 38 | EPHA4 | 1.24177960 |
| 39 | MUSK | 1.22180017 |
| 40 | LMTK2 | 1.21798174 |
| 41 | CAMK2B | 1.21397435 |
| 42 | RIPK4 | 1.19980875 |
| 43 | TRIM28 | 1.17740592 |
| 44 | BRSK1 | 1.17261128 |
| 45 | PRKD3 | 1.16503688 |
| 46 | MAPK15 | 1.15257336 |
| 47 | CSNK1G3 | 1.08804506 |
| 48 | PRPF4B | 1.06947173 |
| 49 | CAMK2A | 1.06715372 |
| 50 | NME2 | 1.05851511 |
| 51 | DMPK | 1.02834773 |
| 52 | EPHA2 | 0.99683129 |
| 53 | NTRK1 | 0.98931905 |
| 54 | SIK3 | 0.98586647 |
| 55 | ADRBK1 | 0.95535324 |
| 56 | PRKCE | 0.94689847 |
| 57 | CAMK2D | 0.94360509 |
| 58 | CDK14 | 0.91140975 |
| 59 | VRK1 | 0.90540549 |
| 60 | MAP2K4 | 0.87173204 |
| 61 | ROCK2 | 0.86889083 |
| 62 | PAK1 | 0.86723016 |
| 63 | EIF2AK1 | 0.86417655 |
| 64 | NTRK2 | 0.85485172 |
| 65 | TAOK2 | 0.84439472 |
| 66 | CAMKK2 | 0.84395842 |
| 67 | IRAK2 | 0.83958370 |
| 68 | PRKCG | 0.82581777 |
| 69 | CSNK1G2 | 0.81650218 |
| 70 | TESK1 | 0.81398326 |
| 71 | PKN1 | 0.81058762 |
| 72 | CDK18 | 0.80879525 |
| 73 | BUB1 | 0.80704987 |
| 74 | CAMK2G | 0.79638731 |
| 75 | CDK5 | 0.78206632 |
| 76 | BMX | 0.77277274 |
| 77 | AURKA | 0.76094697 |
| 78 | SIK2 | 0.75102300 |
| 79 | CDK15 | 0.74051014 |
| 80 | PAK6 | 0.72379350 |
| 81 | PAK3 | 0.71662750 |
| 82 | PRKCI | 0.71212500 |
| 83 | PDK2 | 0.69990929 |
| 84 | MAPKAPK3 | 0.69677970 |
| 85 | DAPK1 | 0.68215417 |
| 86 | CDK11A | 0.65977402 |
| 87 | DAPK3 | 0.65971131 |
| 88 | MAP4K2 | 0.65160363 |
| 89 | AKT3 | 0.63175410 |
| 90 | IRAK1 | 0.61717259 |
| 91 | PTK2 | 0.60753585 |
| 92 | TNK2 | 0.57727864 |
| 93 | MAP3K9 | 0.57388441 |
| 94 | PHKG2 | 0.56955755 |
| 95 | PHKG1 | 0.56955755 |
| 96 | WNK3 | 0.56710105 |
| 97 | ILK | 0.56570770 |
| 98 | TSSK6 | 0.55963367 |
| 99 | DYRK3 | 0.55941307 |
| 100 | LRRK2 | 0.55683396 |
| 101 | FGR | 0.54551371 |
| 102 | SGK223 | 0.54463889 |
| 103 | SGK494 | 0.54463889 |
| 104 | CSNK1G1 | 0.54162297 |
| 105 | IRAK3 | 0.53740293 |
| 106 | TAOK1 | 0.52666488 |
| 107 | ERBB3 | 0.51597550 |
| 108 | PTK2B | 0.51424619 |
| 109 | ABL2 | 0.49787329 |
| 110 | CSNK1A1L | 0.49701971 |
| 111 | DAPK2 | 0.49390953 |
| 112 | NEK6 | 0.49316678 |
| 113 | CDK8 | 0.47282709 |
| 114 | DYRK1A | 0.47036708 |
| 115 | CDK3 | 0.46117046 |
| 116 | TLK1 | 0.46080041 |
| 117 | GRK1 | 0.45502689 |
| 118 | * PRKACA | 0.45065229 |
| 119 | CAMK1 | 0.42553208 |
| 120 | PRKG1 | 0.41623398 |
| 121 | TESK2 | 0.40846278 |
| 122 | EPHB2 | 0.40486892 |
| 123 | CAMKK1 | 0.39941049 |
| 124 | YES1 | 0.38714942 |
| 125 | PRKCA | 0.38040159 |
| 126 | PRKD1 | 0.37917478 |
| 127 | OBSCN | 0.36531219 |
| 128 | WNK1 | 0.36309578 |
| 129 | RAF1 | 0.34779563 |
| 130 | ROCK1 | 0.34535253 |
| 131 | FES | 0.34002861 |
| 132 | EIF2AK3 | 0.32704374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 6.02609279 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.97748763 |
| 3 | Alzheimers disease_Homo sapiens_hsa05010 | 3.87915941 |
| 4 | Huntingtons disease_Homo sapiens_hsa05016 | 3.42884259 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.10280697 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.08757430 |
| 7 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.96640126 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.51483557 |
| 9 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.43430323 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.43012965 |
| 11 | Nicotine addiction_Homo sapiens_hsa05033 | 2.27073140 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.24076248 |
| 13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.21786976 |
| 14 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.93125209 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.68296578 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.67786733 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.66542757 |
| 18 | RNA polymerase_Homo sapiens_hsa03020 | 1.63719820 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.63487285 |
| 20 | GABAergic synapse_Homo sapiens_hsa04727 | 1.56725235 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.52081063 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43509840 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.38039871 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.29672868 |
| 25 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.29513348 |
| 26 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.28874398 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.28111417 |
| 28 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24354300 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.23076388 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16811821 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.16021265 |
| 32 | Circadian entrainment_Homo sapiens_hsa04713 | 1.15543975 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.12991798 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09945891 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.09789644 |
| 36 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.09744108 |
| 37 | Phototransduction_Homo sapiens_hsa04744 | 1.09045533 |
| 38 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.00869465 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.98480823 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97862095 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.96042287 |
| 42 | Long-term depression_Homo sapiens_hsa04730 | 0.89935336 |
| 43 | Cocaine addiction_Homo sapiens_hsa05030 | 0.88925798 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88862598 |
| 45 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.87866722 |
| 46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.87048980 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74532612 |
| 48 | Long-term potentiation_Homo sapiens_hsa04720 | 0.74228596 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73278537 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71795778 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 0.71569990 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71501721 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71100096 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.70838353 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 0.70467175 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65606043 |
| 57 | Renin secretion_Homo sapiens_hsa04924 | 0.64053654 |
| 58 | Salivary secretion_Homo sapiens_hsa04970 | 0.63409382 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.57663011 |
| 60 | Insulin secretion_Homo sapiens_hsa04911 | 0.57414745 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56732508 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55344832 |
| 63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55221688 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54963089 |
| 65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54911511 |
| 66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54514741 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52720589 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52708210 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51866075 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51726888 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.50529835 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50274916 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49201606 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.49169764 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.48877043 |
| 76 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.48662091 |
| 77 | Gap junction_Homo sapiens_hsa04540 | 0.48006712 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47109863 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46346880 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.45775599 |
| 81 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.45687930 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45427735 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45191350 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44862031 |
| 85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44663198 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44534259 |
| 87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44222350 |
| 88 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44208794 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44054226 |
| 90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43477142 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.43195568 |
| 92 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.43029303 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42800904 |
| 94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42121390 |
| 95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.40773181 |
| 96 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.39792345 |
| 97 | Purine metabolism_Homo sapiens_hsa00230 | 0.38635328 |
| 98 | Allograft rejection_Homo sapiens_hsa05330 | 0.36175171 |
| 99 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.33903234 |
| 100 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.33353815 |
| 101 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.32538632 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.31898237 |
| 103 | Carbon metabolism_Homo sapiens_hsa01200 | 0.31819756 |
| 104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31200849 |
| 105 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.30844477 |
| 106 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.30810127 |
| 107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.29529801 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29392826 |
| 109 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.29105352 |
| 110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28952018 |
| 111 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.28670956 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28133618 |
| 113 | Melanogenesis_Homo sapiens_hsa04916 | 0.27936625 |
| 114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27790357 |
| 115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27597232 |
| 116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27551805 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26973929 |
| 118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.26319437 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.22525511 |
| 120 | Basal transcription factors_Homo sapiens_hsa03022 | 0.20347691 |
| 121 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.20208363 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.18877540 |
| 123 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.18832000 |
| 124 | Salmonella infection_Homo sapiens_hsa05132 | 0.18252415 |
| 125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.16826921 |
| 126 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.14208321 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.12395216 |
| 128 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.12199310 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12138584 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.11797697 |
| 131 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.10626945 |
| 132 | Malaria_Homo sapiens_hsa05144 | 0.08746134 |
| 133 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.07703845 |

